Association of chronic kidney disease, ethnicity and socioeconomic status with COVID-19 hospitalisation and mortality: a UK Biobank study
=========================================================================================================================================

* Thomas J Wilkinson
* Courtney J Lightfoot
* Alice C. Smith
* Thomas Yates
* Kamlesh Khunti
* Francesco Zaccardi

## Abstract

*   In individuals with chronic kidney disease (CKD), Black and South Asian ethnic groups are twice as likely to have severe COVID-19 compared to White participants, whilst the most socially deprived groups are at a 50-60% increased risk of severe COVID-19.

*   This study is the first to highlight the association between ethnicity and socioeconomic deprivation and the risk of severe COVID-19 among those with CKD in the UK.

*   Interventions to reduce morbidity and mortality amongst these groups and policy and practice improvements are needed to address the broad disparity among CKD patients.

Keywords
*   COVID-19
*   ethnicity
*   health inequalities
*   socioeconomic status
*   chronic kidney disease

## Introduction

In the UK, as of July 2021, there have been over 4.5 million confirmed cases of coronavirus disease-2019 (COVID-19) and over 150,000 deaths caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]. Data are being reported on subpopulations most at risk of COVID-19 and its severest forms. Age, ethnicity, and socioeconomic position fundamental components in health inequality strongly influence health outcomes for both infectious and non-communicable diseases, and COVID-19 has further exposed the strong association between these and adverse health outcomes [2].

There is substantial evidence that a disproportionate impact of COVID-19 exists on Black and South Asian ethnic groups [3]. Individuals from these groups are more likely to be infected by SARS-CoV-2 and have an increased risk of intensive care admission compared to those of White ethnicity [4]. The mortality risk from COVID-19 among Black and Asian ethnic minority groups approximately twice that of White patients [2, 5-8]. Socioeconomic status is also a key factor in COVID-19 outcome [9, 10] and mortality rates from COVID-19 in the most deprived areas are more than double that of least deprived areas [6, 7, 11].

Many of the ethnic and socioeconomic disparities that increase susceptibility to COVID-19 also make individuals vulnerable to chronic kidney disease (CKD). The risk of CKD is higher in ethnic minority groups compared with White individuals at every CKD stage [12] and CKD is associated with greater hospitalisation and mortality from COVID-19 [7, 13-15]. Whilst the aetiology of CKD involvement is multifactorial [13], the interactions with ethnic and socioeconomic status have not been studied. Previous data suggests that inequalities in COVID-19 deaths by ethnic group exist among people with similar pre-existing conditions including CKD [7]; however, to our knowledge no study has investigated the role of ethnicity and socioeconomic status on COVID-19 severity among those with CKD, or whether existence of CKD increases risk in these groups further.

## Short Methods

### Data source

This study uses UK Biobank data. Participants from the general population were recruited between March 2006 and December 2010 [16]. UK Biobank was approved by the North West Multi-Centre Research Ethics Committee (11/NW/0382). All participants provided informed consent. This work was conducted under application number 52553.

### Population

Participants with CKD were identified by a creatinine-derived eGFR of <60 ml/min/1.73m2 and/or a urinary albumin/creatinine ratio (ACR) ≥3□mg/mmol (ACR A2-A3). Participants with an eGFR of ≥60 ml/min/1.73m2 and an ACR <3 mg/mmol were included as a non-CKD comparison group.

### Exposure

Our exposures of interest were ethnicity and socioeconomic deprivation status, obtained at baseline. Ethnicity was classified using Office of National Statistics groupings. To provide sufficient numbers for analysis, the analysis was limited to include White, South Asian, and Black ethnic groups; South Asian and Black individuals form the two largest minority ethnic groups within the UK. These groups have previously been used in UK Biobank analyses [8, 9, 17].

The Townsend deprivation index was used as a composite measure of socioeconomic status based on employment, car and home ownership, and household overcrowding; a lower value represents a higher socioeconomic status. Participants were classified into three groups: ‘least deprived’: less than -2.00; ‘average’: -2.00 to 1.99; and ‘most deprived’: ≧2.00 [18].

### Outcomes

Public Health England provided SARS-CoV-2 test results (available from 16th March to 3rd May 2021). Records were linked to inpatient Hospital Episode Statistics and national mortality registers (data available to 23rd March 2021). As per previous studies [19], the primary outcome was ‘severe’ COVID-19 defined as a composite of a positive SARS-CoV-2 related hospital admission or death from COVID-19 (ICD-10 code U07.1/U07.2).

### Confounders

Covariates included: current age (calculated on date of SARS-CoV-2 test from original baseline assessment); sex; obesity (defined using body fat%); and number of cancer (including any incidence of cancer and leukaemia) and non-cancer reported illnesses (including cardiovascular disease and diabetes).

### Statistical analysis

Analysis was based on a whole population level approach [20], with severe COVID-19 cases compared to the remaining UK Biobank population. Maximally-adjusted complete-case logistic regression models were used to analyse the associations between ethnicity, socioeconomic status, and severe COVID-19. The results are reported as odds ratios (ORs) with 95% confidence intervals (95%CI). To investigate whether CKD modified the association between ethnicity/socioeconomic status and severe COVID-19 risk, a likelihood ratio test was conducted comparing two models, with and without an interaction term. Data was analysed using IBM SPSS (V26.0).

## Results

### Participant characteristics

Data were available for 459,042 participants, of whom 10,480 (2.3%) had CKD. In those with CKD, the median (25-75th percentile) age was 76.0 (72.0-79.0) years, and 47.9% were males. The median eGFR was 54.2 (45.5-57.1) ml/min/1.73m2 . The majority of CKD participants were White (94.2%) (Table 1).

View this table:
[Table 1.](http://medrxiv.org/content/early/2021/08/04/2021.08.02.21261469/T1)

Table 1. Basic participant characteristics

There were 5538 cases of severe COVID-19: 247 (2.4%) occurred in participants with CKD and 5291 (1.2%) in those without (Table 1). Participants with CKD were 1.6 times more likely to have had severe COVID-19 (OR: 1.58; 95%CI: 1.38-1.82; P<0.001).

### Ethnicity and risk of severe COVID-19 in those with CKD

Differences in the crude frequency of severe COVID-19 cases across ethnic groups are depicted in Figure 1: overall, in participants with CKD, severe COVID-19 was more prevalent across all ethnic groups compared to White participants. In participants with CKD, compared to White group, Black ethnic individuals were approximately 2.3 times more likely to have had severe COVID-19 (OR: 2.26; 1.34-3.80; P=0.002) and those of South Asian ethnicity 2.1 times more likely (OR: 2.07; 1.07-4.00); P=0.032; Figure 2). A similar pattern of association was observed in participants without CKD, with no evidence of an interaction between presence of CKD and ethnicity (P=0.363; Figure 2).

![Figure 1.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2021/08/04/2021.08.02.21261469/F1.medium.gif)

[Figure 1.](http://medrxiv.org/content/early/2021/08/04/2021.08.02.21261469/F1)

Figure 1. Proportion of COVID-19 positive inpatient tests, deaths, and severe COVID-19 across ethnic and socioeconomic deprivation groups, in participants with and without CKD

![Figure 2.](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2021/08/04/2021.08.02.21261469/F2.medium.gif)

[Figure 2.](http://medrxiv.org/content/early/2021/08/04/2021.08.02.21261469/F2)

Figure 2. Likelihood of severe COVID-19 across ethnic and socioeconomic deprivation groups, in participants with and without CKD

### Socioeconomic deprivation and risk of severe COVID-19 in those with CKD

Severe COVID-19 was more prevalent in participants with vs without CKD across all socioeconomic groups and was progressively more common in groups with a greater deprivation (**Figure 1**). In participants with CKD, compared to the least deprived group individuals in the most deprived group were 63% more likely to have severe COVID-19 (OR: 1.63; 1.15-2.31; P=0.007), whilst those in the average group were 50% more likely to have severe COVID-19 (OR: 1.50; 1.10-2.04; P=0.011; **Figure 2**). There was no evidence of an interaction between CKD and socioeconomic status (P=0.559).

## Discussion

In a cohort study of almost 500,000 UK adults, we report a number of novel findings: (1) the frequency of severe COVID-19 cases was higher in participants with CKD compared to those without CKD, regardless of ethnicity and socioeconomic status; (2) in those with CKD, accounting for potential confounders, Black and South Asian ethnic groups were around twice as likely to have severe COVID-19 compared to White participants and the most socially deprived groups were at 50%-60% increased risk of severe COVID-19; (3) associations of ethnicity or deprivation with severe COVID-19 were similar, regardless of the presence of CKD.

Whilst previous studies have shown that CKD is associated with an increased risk of hospitalisation and death from COVID-19 [7, 13, 14], to our knowledge no previous data has explored how this risk differs across ethnic and socioeconomic groups in relation to CKD. Our results are consistent with the stark ethnic inequalities evident in recent studies of

COVID-19 mortality and outcomes [3, 4], including an analysis of 17 million people in England using the OpenSAFELY platform [5]. We found that the likelihood of severe COVID 19 was increased in the most deprived CKD socioeconomic groups. This finding supports previous reports in the general population [6, 7, 9-11]. Notably, as we did not find evidence that associations for ethnicity and socioeconomic status were modified by presence of CKD, the relative risk of severe COVID-19 was similar in participants with and without CKD and the presence CKD similarly increased the relative risk irrespective of ethnicity or deprivation.

Many explanations exist as to why there may be an elevated risk of SARS-CoV-2 infection in minority ethnic or socially deprived groups. Possible reasons include living in deprived areas; working in high-exposure or front-line occupations; living in large, multigenerational households; a higher burden of comorbidity; discrimination; and poor access to health services [3, 5, 9].

There are limitations to this analysis. The cohort consists of volunteers, meaning results may not be entirely generalisable to the whole UK [18]. We used data, particularly CKD classification, from the baseline assessments recorded >10□years ago and, as such, the current health status of participants (e.g., changes in kidney function) cannot be determined. Our CKD group had mild disease staging and findings may differ as disease severity increases. We were only able to categorise ethnicity into three broad categories, rather than considering disaggregated groupings. Disaggregation into specific ethnicity groups has revealed differences in COVID-19 outcomes [5].

This study is the first to detail the association of ethnicity and socioeconomic deprivation with the risk of severe COVID-19 in relation to presence of CKD. These findings are of importance in informing interventions to reduce morbidity and mortality amongst these groups and policy and practice improvements are needed to address the broad disparity among CKD patients.

## Supporting information

Supplementary material [[supplements/261469_file02.docx]](pending:yes)

## Data Availability

Data available through UK Biobank.

## Conflict of interest

TJW, FZ, CJL, ACS, TY: None. KK: Director of the University of Leicester Centre for Ethnic Health Research, Trustee of the South Asian Health Foundation and Chair of the Ethnicity Subgroup of SAGE.

## Acknowledgments

KK is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM) and the NIHR Leicester Biomedical Research Centre (BRC). TY is funded by a grant from the UKRI-DHSC COVID-19 Rapid Response Rolling Call (MR/V020536/1).

## Footnotes

*   **Funding** This work was supported by the Stoneygate Trust, NIHR Leicester Biomedical Research Centre, Leicester Real World Evidence Unit, University of Leicester, and NIHR Applied Research Collaboration (ARC) East Midlands. The study is registered as UK Biobank Application Number 52553.

*   KK is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM) and the NIHR Leicester Biomedical Research Centre (BRC). TY is funded by a grant from the UKRI-DHSC COVID-19 Rapid Response Rolling Call (MR/V020536/1).

*   Received August 2, 2021.
*   Revision received August 2, 2021.
*   Accepted August 4, 2021.


*   © 2021, Posted by Cold Spring Harbor Laboratory

This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)

## References

1.  1.UK Government. Coronavirus (COVID-19) in the UK. Assessed July 15, 2020. [https://coronavirus.data.gov.uk](https://coronavirus.data.gov.uk)
    
    

2.  2.Yaya S, Yeboah H, Charles CH, Otu A, Labonte R. Ethnic and racial disparities in COVID-19-related deaths: counting the trees, hiding the forest. BMJ Glob Health. 2020;5(6):e002913. doi: 10.1136/bmjgh-2020-002913.
    
    [FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6NToiYm1qZ2giO3M6NToicmVzaWQiO3M6MTE6IjUvNi9lMDAyOTEzIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjEvMDgvMDQvMjAyMS4wOC4wMi4yMTI2MTQ2OS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

3.  3.Katikireddi SV, Lal S, Carrol ED, et al. Unequal impact of the COVID-19 crisis on minority ethnic groups: a framework for understanding and addressing inequalities. J Epidemiol Community Health. 2021;jech-2020-216061. doi: 10.1136/jech-2020-216061.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiamVjaCI7czo1OiJyZXNpZCI7czoxODoiamVjaC0yMDIwLTIxNjA2MXYxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjEvMDgvMDQvMjAyMS4wOC4wMi4yMTI2MTQ2OS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

4.  4.Sze S, Pan D, Nevill CR, et al. Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine. 2020;29:100630. doi: 10.1016/j.eclinm.2020.100630.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.eclinm.2020.100630&link_type=DOI) 

5.  5.Mathur R, Rentsch CT, Morton CE, et al. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021;397(10286):1711–1724. doi: 10.1016/S0140-6736(21)00634-6.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(21)00634-6&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F08%2F04%2F2021.08.02.21261469.atom) 

6.  6.Prats-Uribe A, Paredes R, Prieto-Alhambra D. Ethnicity, comorbidity, socioeconomic status, and their associations with COVID-19 infection in England: a cohort analysis of UK Biobank data. medRxiv. 2020. doi: 10.1101/2020.05.06.20092676
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wNS4wNi4yMDA5MjY3NnYzIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjEvMDgvMDQvMjAyMS4wOC4wMi4yMTI2MTQ2OS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

7.  7.Public Health England. Disparities in the risk and outcomes of COVID-19. 2020. Assessed July 15, 2020. [https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment\_data/file/908434/Disparities\_in\_the\_risk\_and\_outcomes\_of\_COVID\_August\_2020\_update.pdf](https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment\_data/file/908434/Disparities\_in\_the\_risk\_and\_outcomes\_of\_COVID_August_2020_update.pdf)
    
    

8.  8.Batty GD, Gaye B, Gale C, Hamer M, Lassale CE. Explaining ethnicity disparities in COVID-19 mortality: population-based, prospective cohort study. medRxiv. 2021. doi: 10.1101/2021.02.07.21251079
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMS4wMi4wNy4yMTI1MTA3OXYyIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjEvMDgvMDQvMjAyMS4wOC4wMi4yMTI2MTQ2OS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

9.  9.Raisi-Estabragh Z, McCracken C, Bethell MS, et al. Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25 (OH)-vitamin D status: study of 1326 cases from the UK Biobank. J Pub Health. 2020;42(3):451–460. doi: 10.1093/pubmed/fdaa095
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/pubmed/fdaa095&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32556213&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F08%2F04%2F2021.08.02.21261469.atom) 

10. 10.Niedzwiedz CL, O’Donnell CA, Jani BD, et al. Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Med. 2020;18(1):160. doi: 10.1186/s12916-020-01640-8.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s12916-020-01640-8&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F08%2F04%2F2021.08.02.21261469.atom) 

11. 11.Woodward M, Peters SAE, Harris K. Social deprivation as a risk factor for COVID-19 mortality among women and men in the UK Biobank: nature of risk and context suggests that social interventions are essential to mitigate the effects of future pandemics. J Epidemiol Community Health. 2021:jech-2020-215810. doi: 10.1136/jech-2020-215810.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiamVjaCI7czo1OiJyZXNpZCI7czoxODoiamVjaC0yMDIwLTIxNTgxMHYxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjEvMDgvMDQvMjAyMS4wOC4wMi4yMTI2MTQ2OS5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

12. 12.Longino K, Kramer H. Racial and Ethnic Disparities, Kidney Disease, and COVID-19: A Call to Action. Kidney Med. 2020;2(5):509–510. doi: 10.1016/j.xkme.2020.07.001.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.xkme.2020.07.001&link_type=DOI) 

13. 13.Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838. doi: 10.1016/j.kint.2020.03.005.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.kint.2020.03.005&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32247631&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F08%2F04%2F2021.08.02.21261469.atom) 

14. 14.Henry BM, Lippi G. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol. 2020;52(6):1193–1194. doi: 10.1007/s11255-020-02451-9.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s11255-020-02451-9&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32222883&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F08%2F04%2F2021.08.02.21261469.atom) 

15. 15.Singh AK, Gillies CL, Singh R, et al. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis. Diabetes Obes Metab. 2020;22(10):1915–1924. doi: 10.1111/dom.14124.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/dom.14124&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32573903&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F08%2F04%2F2021.08.02.21261469.atom) 

16. 16.Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. doi: 10.1371/journal.pmed.1001779.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pmed.1001779&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=25826379&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F08%2F04%2F2021.08.02.21261469.atom) 

17. 17.Nicholl BI, Smith DJ, Cullen B, et al. Ethnic differences in the association between depression and chronic pain: cross sectional results from UK Biobank. BMC Fam Pract. 2015 Oct 6;16:128. doi: 10.1186/s12875-015-0343-5.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s12875-015-0343-5&link_type=DOI) 

18. 18.Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am J Epidemiol. 2017;186(9):1026–1034. doi: 10.1093/aje/kwx246.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/aje/kwx246&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=28641372&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2021%2F08%2F04%2F2021.08.02.21261469.atom) 

19. 19.Mutambudzi M, Niedwiedz C, Macdonald EB, et al. Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occup Environ Med. 2020;oemed-2020-106731. doi: 10.1136/oemed-2020-106731.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NToib2VtZWQiO3M6NToicmVzaWQiO3M6ODoiNzgvNS8zMDciO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMS8wOC8wNC8yMDIxLjA4LjAyLjIxMjYxNDY5LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

20. 20.Yates T, Zaccardi F, Razieh C, et al. Framework to aid analysis and interpretation of ongoing COVID-19 research [version 1; peer review: 1 approved with reservations]. Wellcome Open Res. 2020;5:208. doi: 10.12688/wellcomeopenres.16227.1.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.12688/wellcomeopenres.16227.1&link_type=DOI)